Epstein–Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen (original) (raw)

• Original Paper
• Published: 06 April 2000

Oncogene volume 19, pages 1801–1806 (2000)Cite this article

• 695 Accesses
• 36 Citations
• Metrics details

Abstract

EBNA-3 (also called EBNA-3A) is one of the EBV encoded nuclear antigens that are necessary for B-cell transformation. EBNA-3 is known to target RBPs, nuclear proteins that also interacts with EBNA-2, EBNA-4 and EBNA-6. In order to identify additional EBNA-3 targets, an EBV-transformed human lymphocyte cDNA library was screened in the yeast two-hybrid system with N-terminus truncated EBNA-3 that cannot interact with RBP-Jκ. A clone, encoding Xap-2 protein, a cellular partner of Hepatitis B virus X-antigen was isolated. This protein is also known as the p38 subunit of the aryl hydrocarbon receptor complex (ARA9). The specific binding to EBNA-3 was confirmed by showing that the GST-Xap-2 precipitated EBNA-3 from CV1 cells that were infected with recombinant vaccinia virus expressing EBNA-3. Deletion of the C-terminus of Xap-2 eliminated the binding. Fusion with green fluorescent protein showed that Xap-2 is preferentially cytoplasmic but translocates to the nucleus upon expression of EBNA-3.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 50 print issues and online access

$259.00 per year

only $5.18 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Similar content being viewed by others

References

• Allday MJ, Crawford DH and Thomas JA . 1993 J Gen Virol 74: 361–369
• Carver LA and Bradfield CA . 1997 J Biol Chem 272: 11452–11456
• Carver LA, LaPres JJ, Jain S, Dunham EE and Bradfield CA . 1998 J Biol Chem 273: 33580–33587
• Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G and Masucci MG . 1992 Proc Natl Acad Sci USA 89: 5862–5866
• Hahn ME, Karchner SI, Shapiro MA and Perera SA . 1997 Proc Natl Acad Sci USA 94: 13743–13748
• Johannsen E, Miller CL, Grossman SR and Kieff E . 1996 J Virol 70: 4179–4183
• Kaise C, Michaelis S and Mitchell A . 1994 Cold Spring Harbor Laboratory Course Manual CSHL Press pp 171–173
• Kashuba E, Pokrovskaja K, Klein G and Szekely L . 1999 J Human Virol 2: 33–37
• Kobayashi A, Numayama-Tsuruta K, Sogawa K and Fujii-Kuriyama Y . 1997 J Biochem 122: 703–710
• Krauer KG, Belzer DK, Liaskou D, Buck M, Cross S, Honjo T and Sculley T . 1998 Virology 252: 418–430
• Krauer KG, Kienzle N, Young DB and Sculley TB . 1996 Virology 226: 346–353
• Kuzhandaivelu N, Cong YS, Inouye C, Yang WM and Seto E . 1996 Nucleic Acids Res 24: 4741–4750
• Meyer BK, Pray-Grant MG, Vanden Heuvel JP and Perdew GH . 1998 Mol Cell Biol 18: 978–988
• Radkov SA, Bain M, Farrell PJ, West M, Rowe M and Allday MJ . 1997 J Virol 71: 8552–8562
• Robertson ES, Lin J and Kieff E . 1996 J Virol 70: 3068–3074
• Strobl LJ, Hofelmayr H, Stein C, Marschall G, Brielmeier M, Laux G, Bornkamm GW and Zimber-Strobl U . 1997 Immunobiology 198: 299–306
• Szekely L, Chen F, Teramoto N, Ehlin-Henriksson B, Pokrovskaja K, Szeles A, Manneborg-Sandlund A, Lowbeer M, Lennette ET and Klein G . 1998 J Gen Virol 79: 1445–1452
• Szekely L, Pokrovskaja K, Jiang WQ, de The H, Ringertz N and Klein G . 1996 J Virol 70: 2562–2568
• Szekely L, Pokrovskaja K and Klein G . 1997 Cell Growth Differ 8: 599–609
• Tomkinson B, Robertson E and Kieff E . 1993 J Virol 67: 2014–2025
• Vaziri C and Faller DV . 1997 J Biol Chem 272: 2762–2769
• Waltzer L, Perricaudet M, Sergeant A and Manet E . 1996 J Virol 70: 5909–5915
• Yamaguchi K, Near RI, Matulka RA, Shneider A, Toselli P, Trombino AF and Sherr DH . 1997 J Immunol 158: 2165–2173
• Zhao B, Marshall DR and Sample CE . 1996 J Virol 70: 4228–4236

Download references

Acknowledgements

We thank Lena Norrenius for the excellent technical assistance and Klas G Wiman for the GST-ARF plasmids. This work was supported by Cancerfonden and by a matching grant from the Concern Foundation, Los Angeles, the Cancer Research Institute, New York.

Author information

Authors and Affiliations

1. Microbiology and Tumor Biology Centre (MTC) Karolinska Institute, S-171 77, Stockholm, Sweden
   Elena Kashuba, Vladimir Kashuba, Katja Pokrovskaja, George Klein & Laszlo Szekely

Authors

1. Elena Kashuba
   You can also search for this author inPubMed Google Scholar
2. Vladimir Kashuba
   You can also search for this author inPubMed Google Scholar
3. Katja Pokrovskaja
   You can also search for this author inPubMed Google Scholar
4. George Klein
   You can also search for this author inPubMed Google Scholar
5. Laszlo Szekely
   You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Kashuba, E., Kashuba, V., Pokrovskaja, K. et al. Epstein–Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen .Oncogene 19, 1801–1806 (2000). https://doi.org/10.1038/sj.onc.1203501

Download citation

• Received: 25 October 1999
• Revised: 31 January 2000
• Accepted: 31 January 2000
• Published: 06 April 2000
• Issue Date: 30 March 2000
• DOI: https://doi.org/10.1038/sj.onc.1203501

Keywords

This article is cited by